NCT00763503View on ClinicalTrials.gov

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions

Plaque-type Psoriasis

Interventions

DRUG

CD 2027

3µg/g Oily Spray

Trial Locations (3)

71913

Burke Pharmaceutical Research, Hot Springs

77845

J & S Studies, Bryan

78759

DermResearch, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY